Healthcare & Medical Investment Corporation (TYO:3455)

TYO:3455 Revenue

In the fiscal year ending January 31, 2026, Healthcare & Medical Investment had annual revenue of 5.18B JPY with 2.88% growth. Healthcare & Medical Investment had revenue of 2.63B in the half year ending January 31, 2026, with 8.03% growth.

• Revenue: 5.18B
• Revenue Growth: +2.88%
• P/S Ratio: 7.62
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 39.51B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jan 31, 2026	5.18B	144.84M	2.88%
Jan 31, 2025	5.04B	160.34M	3.29%
Jan 31, 2024	4.88B	-126.46M	-2.53%
Jan 31, 2023	5.00B	850.41M	20.48%
Jan 31, 2022	4.15B	72.00M	1.76%

Data Source: S&P Global Market Intelligence Last updated: Jan 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 19, 2026

Data Sources Report a data error